Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis.
Anastasilakis, Athanasios D
Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis. [electronic resource] - Endocrine journal Jul 2008 - 613-6 p. digital
Publication Type: Clinical Trial; Journal Article
1348-4540
10.1507/endocrj.k07e-123 doi
Aged
Alkaline Phosphatase--blood
Bone Density
Bone Density Conservation Agents--therapeutic use
Calcium--blood
Female
Follow-Up Studies
Humans
Osteoporosis, Postmenopausal--blood
Parathyroid Hormone--blood
Phosphorus--blood
Teriparatide--administration & dosage
Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis. [electronic resource] - Endocrine journal Jul 2008 - 613-6 p. digital
Publication Type: Clinical Trial; Journal Article
1348-4540
10.1507/endocrj.k07e-123 doi
Aged
Alkaline Phosphatase--blood
Bone Density
Bone Density Conservation Agents--therapeutic use
Calcium--blood
Female
Follow-Up Studies
Humans
Osteoporosis, Postmenopausal--blood
Parathyroid Hormone--blood
Phosphorus--blood
Teriparatide--administration & dosage